cellestia-biotech-employee

Dr. Rajwinder Lehal

Chief Scientific Officer
Board Member

Rajwinder is a PhD with 13+ years of experience in cancer research. He graduated from University of Toronto with a M.Sc degree and investigated signaling cascades implicated in human cancers and cancer stem cells. He has obtained his PhD degree from Swiss Federal Institute of Technology, Lausanne (EPFL). Since 2007, he has been working at Swiss Institute for Experimental Cancer Research-EPFL, where he established a drug discovery platform to discover and develop novel anti- cancer therapeutics. He is the recipient of several academic awards. During his undergraduate studies he was awarded Canadian Genetic Disease Network scholarship. He is a winner of American Association for Cancer Research-Scholar in Training award, University of Toronto fellowship, Frank Fletcher Memorial scholarship for cancer research and Al and Hannah Peryl Graduate student scholarship. Based on his drug discovery research, he was awarded INNOGRANT and ENABLE grant by Vice Presidency for Innovation and Technology Transfer at EPFL. Dr. Lehal was selected to Swiss National team of Venture Leaders (2013). In 2014, he co-founded Cellestia Biotech AG with the aim of developing innovative therapeutics for cancer treatment. At Cellestia Biotech AG, he serves as Chief Scientific Officer and serves on the Board of Directors. Linkedin Profile

PROFESSIONAL CAREER

2014-today
Cellestia Biotech AG, Basel, Switzerland (& Lausanne, Switzerland)
Member of the Board of Directors & Chief Scientific Officer & co-founder

2012-2014
Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland
Post-Doctoral fellow

2007-2011
Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland
Doctoral fellow

2003-2007
Toronto General Research Institute (TGRI), Canada
Graduate Fellow

EDUCATION / DEGREES

2013-2013
Management of Biotech, Pharma and Medtech Ventures, Management of Technology- EPFL

2007-2011
PhD studies in drug discovery and cancer research, Swiss Institute for Experimental Cancer Research- EPFL

2003-2007
Master of Science in breast cancer research, Department of Laboratory Medicine and Pathobiology , University of Toronto, Canada

1999-2002
Bachelor of Science (Honors), Department of Biology, York University, Toronto, Canada